Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of immunomodulatory drugs. It is notably involved in the development of analogs related to thalidomide, designed to enhance anti-inflammatory, antitumor, and cereblon-binding activities. Its fluorinated structure improves metabolic stability and bioavailability, making it valuable in oncology drug discovery, especially for hematological cancers such as multiple myeloma. Additionally, it supports structure-activity relationship (SAR) studies to optimize potency and reduce off-target effects in new therapeutic agents.